Tran predicts 10 to 20 gene therapy approvals annually by 2030
Andy Tran · CRISPR 2.0 and the Future of Gene Therapies · Oct 5, 2019 · at 2:23
Andy Tran of a16z projects future regulatory approval rates for gene therapies during a presentation on CRISPR and gene therapies.
0:00 / 0:05exact quote · 5.3s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“We're expecting at least 10 to 20 gene therapy approvals per year by the end of the decade.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Andy Tran
Andy Tran: Gene Editing Enables Curative Single-Dose Treatments
“Of course, this is certainly a big paradigm shift and very exciting as these technologies have given us the power to precisely target And eliminate the origin of disease, as well as be very curative with just a single dose of the drug.”
Tran: CRISPR is evolving into a cellular search engine platform
“Instead of just this pair of molecular scissors that everyone talks about, the biggest recent shift in the field is this push towards making CRISPR a search engine platform of the cell.”
Andy Tran: Gene therapy winners will pair platforms with disease-specific optimization
“Regardless of the type of vector that you're engineering, we believe the winners in the space are the ones that could harness a specific platform and marry it with very thoughtful optimization towards specific disease areas.”
Tran: Metagenomic mining will uncover genome editing systems beyond CRISPR
“As we continue to mine new metagenomic data of new species, it's not crazy to think that perhaps even CRISPR itself is by no means the final frontier of genome engineering.”